Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

An 8 day, randomised, double blind, 3-way crossover trial of repeat doses of intranasal GSK256066 and fluticasone propionate in the Vienna Challenge Chamber in subjects with seasonal allergic rhinitis (SAR)
GSK256066
IPR110723
NCT00612820
Rhinitis, Allergic, Seasonal
Phase 2
 
May 2013

Powered by ideaPoint, Inc.